Sucampo and National Cherry Blossom Festival Announce Sucampo as Host and 'Step Into Spring' Program Sponsor for 2014
March 04 2014 - 10:00AM
Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP) and the
National Cherry Blossom Festival (Festival) today announced their
ongoing partnership to support the historic celebration of Japan's
gift of cherry trees. Built on a passion for science and dedicated
to supporting good health, Sucampo is co-sponsoring with the
Festival this year's "Step Into Spring" fitness program. This
program features free exercise and wellness classes over the course
of the three weeks during the Festival, encouraging a healthy
lifestyle for all participants.
"I am pleased to be continuing Sucampo's legacy of supporting
the National Cherry Blossom Festival," said Peter Greenleaf,
Sucampo's Chief Executive Officer. "We are excited that this year's
Festival includes a focus on health and wellness, and we look
forward to launching the 'Step into Spring' program and bringing
messages about the importance of healthy living to Festival
participants."
Expanding from successes in Japan by its founders Ryuji Ueno,
M.D, Ph.D., Ph.D., and Sachiko Kuno, Ph.D., Sucampo was founded in
1996 to pursue biopharmaceutical research and development in the
United States. This is the third year that Sucampo supports the
Festival as a Host sponsor. Each year, the Festival focuses on
cultural collaboration and supporting the arts, culture and the
environment.
The 2014 Festival commemorates the 102nd anniversary of the gift
of 3,000 cherry trees from Tokyo to Washington, DC. More than 1.5
million people visit Washington, DC each year to admire the
blossoming trees and participate in diverse and creative
programming that make up the nation's most famous springtime
celebration. This year's festivities will take place Thursday,
March 20, through Sunday, April 13. For more information, visit
nationalcherryblossomfestival.org.
About the National Cherry Blossom Festival
The National Cherry Blossom Festival is the nation's greatest
springtime celebration. The 2014 Festival, March 20 – April 13,
includes three spectacular weeks and four weekends of events
featuring diverse and creative programming promoting traditional
and contemporary arts and culture, natural beauty, and community
spirit. The 2014 Festival commemorates the 102nd anniversary of the
gift of the cherry blossom trees and the enduring friendship
between the United States and Japan.
About Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. is focused on the discovery,
development and commercialization of drugs based on ion channel
activators knows as prostones. Discovered by the company's
scientific co-founder, Dr. Ryuji Ueno, prostones are naturally
occurring fatty acid metabolites with unique physiological
activities. Sucampo has two marketed products – AMITIZA® and
RESCULA® – and a pipeline of prostone-based product candidates in
clinical development. A global company, Sucampo is headquartered in
Bethesda, Maryland, and has operations in Japan, the United Kingdom
and Switzerland. For more information, please visit
www.sucampo.com.
The Sucampo logo and the tagline, The Science of Innovation, are
registered trademarks of Sucampo AG. AMITIZA is a registered
trademark of Sucampo AG. RESCULA is a registered trademark of
R-Tech Ueno, Ltd, and has been licensed to Sucampo AG.
Sucampo Forward-Looking Statement
This press release contains "forward-looking statements" as that
term is defined in the Private Securities Litigation Reform Act of
1995. These statements are based on management's current
expectations and involve risks and uncertainties, which may cause
results to differ materially from those set forth in the
statements. The forward-looking statements may include statements
regarding product development, product potential, future financial
and operating results, and other statements that are not historical
facts. The following factors, among others, could cause actual
results to differ from those set forth in the forward-looking
statements: the impact of pharmaceutical industry regulation and
health care legislation; Sucampo's ability to accurately predict
future market conditions; dependence on the effectiveness of
Sucampo's patents and other protections for innovative products;
the risk of new and changing regulation and health policies in the
U.S. and internationally and the exposure to litigation and/or
regulatory actions. No forward-looking statement can be guaranteed
and actual results may differ materially from those projected.
Sucampo undertakes no obligation to publicly update any
forward-looking statement, whether as a result of new information,
future events, or otherwise. Forward-looking statements in this
presentation should be evaluated together with the many
uncertainties that affect Sucampo's business, particularly those
mentioned in the risk factors and cautionary statements in
Sucampo's most recent Form 8-K and 10-K, which Sucampo incorporates
by reference.
Follow us on Twitter (@Sucampo_Pharma). Follow us on LinkedIn
(Sucampo Pharmaceuticals).
Twitter
LinkedIn
CONTACT: Silvia Taylor
Senior Vice President, Investor Relations and
Corporate Communications
1-240-223-3718
staylor@sucampo.com
and
Danielle Davis
Communications Manager, National Cherry Blossom Festival
202-638-8374
danielle@downtowndc.org
Sucampo Pharmaceuticals, Inc. (delisted) (NASDAQ:SCMP)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sucampo Pharmaceuticals, Inc. (delisted) (NASDAQ:SCMP)
Historical Stock Chart
From Oct 2023 to Oct 2024